These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 989923)

  • 21. [On changes in the central nervous system in chronic (progressive) bulbar paralysis].
    Polosin IuP
    Arkh Patol; 1967; 29(9):75-7. PubMed ID: 5600463
    [No Abstract]   [Full Text] [Related]  

  • 22. Progressive supranuclear palsy with widespread cerebral lesions.
    Takeuchi T; Shibayama H; Iwai K; Iwata H; Xu M; Kitoh J; Kobayashi H; Iwase S; Nakagawa M; Yamada K
    Clin Neuropathol; 1992; 11(6):304-11. PubMed ID: 1473314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex.
    German DC; White CL; Sparkman DR
    Neuroscience; 1987 May; 21(2):305-12. PubMed ID: 3302759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropathological findings in a case of coexistent progressive supranuclear palsy and Alzheimer's disease.
    Milder DG; Elliott CF; Evans WA
    Clin Exp Neurol; 1984; 20():181-7. PubMed ID: 6568940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.
    Joachim CL; Morris JH; Kosik KS; Selkoe DJ
    Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive supranuclear palsy.
    Steele JC
    Brain; 1972; 95(4):693-704. PubMed ID: 4647151
    [No Abstract]   [Full Text] [Related]  

  • 27. [Supranuclear progressive paralysis (or oculo-facial-cervical dystonia)].
    Probst A; Dufresne JJ
    Schweiz Arch Neurol Neurochir Psychiatr; 1975; 116(1):107-34. PubMed ID: 1153960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Juvenile Alzheimer's disease with cerebellar involvement.
    Vakili ST; Muller J
    Arch Pathol Lab Med; 1987 May; 111(5):480-2. PubMed ID: 3566478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropathologic findings in progressive supranuclear palsy. A brief review with two additional case reports.
    Kida M; Koo H; Grossniklaus HE; Tomsak RL
    J Clin Neuroophthalmol; 1988 Sep; 8(3):161-70. PubMed ID: 2971680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminum toxicity.
    Scholtz CL; Swash M; Gray A; Kogeorgos J; Marsh F
    Clin Neuropathol; 1987; 6(3):93-7. PubMed ID: 3608291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological correlates of extrapyramidal signs in Alzheimer's disease.
    Liu Y; Stern Y; Chun MR; Jacobs DM; Yau P; Goldman JE
    Ann Neurol; 1997 Mar; 41(3):368-74. PubMed ID: 9066358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive supranuclear palsy with fronto-temporal atrophy and various tau-positive abnormal structures.
    Li F; Iseki E; Kosaka K; Nishimura T; Akiyama H; Kato M
    Clin Neuropathol; 1996; 15(6):319-23. PubMed ID: 8937777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electron microscopic study of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome.
    Roy S; Datta CK; Hirano A; Ghatak NR; Zimmerman HM
    Acta Neuropathol; 1974; 29(2):175-9. PubMed ID: 4446944
    [No Abstract]   [Full Text] [Related]  

  • 34. [Widespread argentophilic structures in progressive supranuclear palsy--an autopsy case report].
    Hanihara T; Kubota H; Amano N; Yamaoka K; Yagishita S
    No To Shinkei; 1994 May; 46(5):487-92. PubMed ID: 8060688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Presence of neuritic plaques and neurofibrillary changes in the cerebral cortex of an aged lemuride primate].
    Bons N; Mestre N; Petter A
    C R Acad Sci III; 1991; 313(5):213-9. PubMed ID: 1913260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New form of familial Parkinson-dementia syndrome and progressive supranuclear palsy.
    Ambrosetto P; Bacci A
    Neurology; 1984 Nov; 34(11):1524-5. PubMed ID: 6493510
    [No Abstract]   [Full Text] [Related]  

  • 37. Contribution to clinical pathology of progressive supranuclear palsy (subcortical argyrophilic dystrophy). On the distribution of neurofirbrillary tangles in the basal ganglia and brain-stem and its clinical significance.
    Ishino H; Ikeda H; Otsuki S
    J Neurol Sci; 1975 Apr; 24(4):471-81. PubMed ID: 1117315
    [No Abstract]   [Full Text] [Related]  

  • 38. Argyrophilic grains are not always argyrophilic--distinction from neurofibrillary tangles of diffuse neurofibrillary tangles with calcification revealed by comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
    Acta Neuropathol; 2005 Aug; 110(2):158-64. PubMed ID: 15971055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progressive supranuclear palsy--consideration from neurotological point of view (author's transl)].
    Umeda E
    Rinsho Shinkeigaku; 1977 Nov; 17(11):746-50. PubMed ID: 719970
    [No Abstract]   [Full Text] [Related]  

  • 40. [Morphological changes in the human cerebral cortex in dementia].
    Braak H; Braak E
    J Hirnforsch; 1991; 32(3):277-82. PubMed ID: 1779131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.